0001127602-19-033520.txt : 20191122
0001127602-19-033520.hdr.sgml : 20191122
20191122062327
ACCESSION NUMBER: 0001127602-19-033520
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191120
FILED AS OF DATE: 20191122
DATE AS OF CHANGE: 20191122
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HUTT PETER BARTON
CENTRAL INDEX KEY: 0001171527
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38753
FILM NUMBER: 191238662
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Moderna, Inc.
CENTRAL INDEX KEY: 0001682852
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 813467528
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 TECHNOLOGY SQUARE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 6177146500
MAIL ADDRESS:
STREET 1: 200 TECHNOLOGY SQUARE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: Moderna Therapeutics, Inc.
DATE OF NAME CHANGE: 20160822
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2019-11-20
0001682852
Moderna, Inc.
MRNA
0001171527
HUTT PETER BARTON
C/O MODERNA, INC.
200 TECHNOLOGY SQUARE
CAMBRIDGE
MA
02139
1
Common Stock
2019-11-20
4
M
0
200000
.04
A
203924
D
Common Stock
2019-11-20
4
S
0
200000
20.18
D
3924
D
Stock Option (Right to Buy)
.04
2019-11-20
4
M
0
200000
0
D
2022-03-27
Common Stock
200000
502752
D
The price reported in Column 4 is a weighted average price. The shares sold in multiple transactions at prices ranging from $20.00 to $20.34. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
This option is fully vested and exercisable.
/s/ Jeffrey Cerio, as Attorney-in-Fact
2019-11-22